Drug Delivery System Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

Drug Delivery System Market Overview

The global Drug Delivery System Market is poised for significant growth, with projections indicating a robust expansion from 2025 to 2030. The market, valued at approximately $39.2 billion in 2025, is expected to grow at a compound annual growth rate (CAGR) of 6.8% to 7.5% during the forecast period. This growth is driven by advancements in drug delivery technologies, increasing prevalence of chronic diseases, and the rising demand for patient-friendly drug administration methods.

Market Size and Share Analysis

The market is segmented by product type, including inhalers, injection systems, pen injectors, eye care droppers, and nasal spray systems. Among these, the inhaler segment holds the largest market share, accounting for approximately 28% of the total market in 2025. The injection systems segment follows closely, with a market share of 25%, driven by the increasing adoption of biologics and biosimilars.

Key players in the market include Gerresheimer, Aptar, Silgan, Nemera, Bona Pharma, Guangdong Stone Medicinal Packaging Material Co. Ltd, and Shenzhen BONA Pharma Technology. These companies are focusing on strategic collaborations, product innovations, and geographic expansions to strengthen their market positions. For instance, Gerresheimer has recently invested in advanced manufacturing technologies to enhance its production capabilities for drug delivery devices.

Market Trends and Drivers

The market is witnessing several trends that are shaping its growth trajectory. One of the key trends is the increasing adoption of smart drug delivery systems, which offer precise dosing and real-time monitoring capabilities. Additionally, the growing emphasis on self-administration devices is driving demand for user-friendly and portable drug delivery systems.

Another significant driver is the rising prevalence of chronic diseases such as diabetes, asthma, and cancer, which require long-term medication management. The increasing geriatric population, which is more susceptible to chronic conditions, is also contributing to market growth. Furthermore, the COVID-19 pandemic has accelerated the development and adoption of innovative drug delivery systems, particularly for vaccines and biologics.

Market Segmentation by Product Type

• Inhalers: The inhaler segment is expected to grow at a CAGR of 7.2% from 2025 to 2030, driven by the increasing prevalence of respiratory diseases and the demand for portable and efficient drug delivery solutions.
• Injection Systems: This segment is projected to grow at a CAGR of 6.9%, fueled by the rising adoption of biologics and the need for precise drug administration.
• Pen Injectors: The pen injector segment is anticipated to grow at a CAGR of 7.5%, supported by the increasing use of insulin pens for diabetes management.
• Eye Care Droppers: This segment is expected to grow at a CAGR of 6.5%, driven by the rising incidence of eye disorders and the demand for targeted drug delivery.
• Nasal Spray Systems: The nasal spray system segment is projected to grow at a CAGR of 7.0%, owing to the increasing use of nasal sprays for allergy and migraine treatments.

Market Segmentation by Process

The market is also segmented by process, including controlled release, targeted delivery, and sustained release. The controlled release segment dominates the market, accounting for approximately 40% of the total market share in 2025. This segment is expected to grow at a CAGR of 7.0% from 2025 to 2030, driven by the need for improved patient compliance and reduced dosing frequency.

Market Segmentation by Application

The market is segmented by application into oncology, diabetes, respiratory diseases, cardiovascular diseases, and others. The oncology segment holds the largest market share, accounting for approximately 30% of the total market in 2025. This segment is expected to grow at a CAGR of 7.3% from 2025 to 2030, driven by the increasing prevalence of cancer and the development of targeted therapies.

Market Segmentation by End-Use

The market is segmented by end-use into hospitals, home care settings, and ambulatory surgical centers. The hospitals segment dominates the market, accounting for approximately 45% of the total market share in 2025. This segment is expected to grow at a CAGR of 6.7% from 2025 to 2030, driven by the increasing number of hospital admissions and the need for advanced drug delivery systems in clinical settings.

Regional Analysis

The market is segmented by region into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America holds the largest market share, accounting for approximately 40% of the total market in 2025. This region is expected to grow at a CAGR of 6.9% from 2025 to 2030, driven by the presence of major pharmaceutical companies and the high adoption rate of advanced drug delivery technologies.

Europe follows closely, with a market share of approximately 30% in 2025. The region is expected to grow at a CAGR of 6.7% from 2025 to 2030, driven by the increasing prevalence of chronic diseases and the growing demand for patient-friendly drug delivery systems.

The Asia-Pacific region is expected to witness the highest growth rate, with a CAGR of 8.0% from 2025 to 2030. This growth is attributed to the increasing healthcare expenditure, rising awareness about advanced drug delivery systems, and the growing prevalence of chronic diseases in the region.

Market News on Policy and Companies

Recent policy developments and company activities are shaping the drug delivery system market. For instance, regulatory agencies such as the FDA and EMA are increasingly approving innovative drug delivery systems, which is expected to drive market growth. Additionally, companies are investing in research and development to introduce advanced drug delivery technologies. For example, Aptar recently launched a new nasal spray system that offers improved drug delivery efficiency.

Moreover, strategic collaborations and partnerships are becoming increasingly common in the market. For instance, Gerresheimer and Bona Pharma have entered into a partnership to develop next-generation drug delivery devices. These collaborations are expected to drive innovation and expand the market reach of key players.

Segment Forecasts, 2025 - 2030

The drug delivery system market is expected to witness significant growth across all segments from 2025 to 2030. The inhaler segment is projected to grow at a CAGR of 7.2%, driven by the increasing prevalence of respiratory diseases. The injection systems segment is expected to grow at a CAGR of 6.9%, fueled by the rising adoption of biologics. The pen injector segment is anticipated to grow at a CAGR of 7.5%, supported by the increasing use of insulin pens for diabetes management.

The eye care dropper segment is expected to grow at a CAGR of 6.5%, driven by the rising incidence of eye disorders. The nasal spray system segment is projected to grow at a CAGR of 7.0%, owing to the increasing use of nasal sprays for allergy and migraine treatments. Overall, the market is expected to reach a value of approximately $56.5 billion by 2030, growing at a CAGR of 6.8% to 7.5% during the forecast period.

Conclusion

The global drug delivery system market is set for substantial growth from 2025 to 2030, driven by advancements in drug delivery technologies, increasing prevalence of chronic diseases, and the rising demand for patient-friendly drug administration methods. Key players such as Gerresheimer, Aptar, Silgan, Nemera, Bona Pharma, Guangdong Stone Medicinal Packaging Material Co. Ltd, and Shenzhen BONA Pharma Technology are focusing on strategic collaborations, product innovations, and geographic expansions to strengthen their market positions. With the increasing adoption of smart drug delivery systems and the growing emphasis on self-administration devices, the market is expected to witness significant growth across all segments and regions.